← All stocks

Hims & Hers Health, Inc.

HIMS Mostly scheduled
CIK 0001773751 #1079 in the set updated 21 Sep 2026
Bought (12 mo)
$1.17M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$37.60M
$15.17M on a plan · $22.33M straight out of an exercise
Sold at will
$97.93K
1 of 60 sales
Net
−$36.43M
+$1.08M against sales at will

By person

16 insiders · 61 transactions
66.2×

Mr. Dudum holds 66.2 times base salary in stock. $32.76M of shares against $494.79K in salary for 2025.

Salary from the company's own proxy. The shares are what Mr. Dudum last reported holding, valued at $28.82, the price Class A Common Stock was last bought or sold at on the open market here, on 17 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Okupe Oluyemi
Chief Financial Officer
$16.56M (22) scheduled
−$16.56M
259,657
0.112%
$7.48M
+20.8%
Dudum Andrew
Chief Executive Officer
$11.03M (9) scheduled
−$11.03M
1,136,583
0.490%
$32.76M
−68.7%
Chi Michael
Chief Operating Officer
$3.93M (7) scheduled
−$3.93M
456,660
0.197%
$13.16M
+133.1%
Boughton Soleil
Chief Legal Officer
$2.07M (11) scheduled
−$2.07M
304,270
0.131%
$8.77M
+72.0%
Carroll Patrick Harrison
Chief Medical Officer
$1.20M (2) scheduled
−$1.20M
197,847
0.085%
$5.70M
−7.3%
WELLS DAVID B
Director
$1.17M (1)
+$1.17M
229,808
0.099%
$6.62M
+17.2%
Elshenawy Mohamed
CTO
$1.17M (2) scheduled
−$1.17M
185,556
0.080%
$5.35M
Becklund Irene
PAO
$815.80K (4) scheduled
−$815.80K
13,985
0.006%
$403.05K
+173.4%
Autor Deborah M.
Chief Policy Officer
$726.08K (2) scheduled
−$726.08K
48,961
0.021%
$1.41M
Perez Garcia Andrea G
Director
$97.93K (1)
−$97.93K
83,822
0.036%
$2.42M
+15.2%
Baird Melissa
Chief Operating Officer
805,083
0.347%
$23.20M
+27.6%
Cosgrove Delos M.
Director
67,995
0.029%
$1.96M
+25.0%
Pendarvis Christiane
Director
55,430
0.024%
$1.60M
+131.8%
Manuel Anja
Director
38,671
0.017%
$1.11M
Payne Christopher D
Director
34,863
0.015%
$1.00M
Schultz Kare
Director
26,020
0.011%
$749.90K
Insider
Date
Role
Action
Shares
Price
Amount
WELLS DAVID B
26 May 2026
Director
Buy
48,400
$24.24
$1.17M

What was left out

Form 4 filings counted 119
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 30
Sales straight out of an exercise 29
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 17,838,060
History held since 22 Jan 2021